363 results on '"Gyorki, David E."'
Search Results
2. Neoadjuvant pembrolizumab, dabrafenib and trametinib in BRAFV600-mutant resectable melanoma: the randomized phase 2 NeoTrio trial
3. ASO Visual Abstract: 3D-SARC: A Pilot Study Testing the Use of a 3D Augmented Reality Model with Conventional Imaging as a Preoperative Assessment Tool for Surgical Resection of Retroperitoneal Sarcoma
4. ASO Author Reflections: Augmented Reality 3D Model in Retroperitoneal Sarcomas
5. What is the association of preoperative biopsy with recurrence and survival in retroperitoneal sarcoma? A systematic review by the Australia and New Zealand Sarcoma Association clinical practice guidelines working party
6. Pleomorphic dermal sarcoma of the scalp - A single-centre experience
7. A systematic review of the role of chemotherapy in retroperitoneal sarcoma by the Australia and New Zealand sarcoma association clinical practice guidelines working party
8. The role of radiation therapy in the management of primary retroperitoneal sarcoma: A systematic review and clinical practice guidelines from the Australia and New Zealand Sarcoma Association
9. Management of Locally Recurrent Retroperitoneal Sarcoma in the Adult: An Updated Consensus Approach from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group
10. Perioperative Care: Sarcoma and Melanoma
11. Contributors
12. Major vascular reconstruction in colorectal adenocarcinoma and retroperitoneal sarcoma: A retrospective study of safety and margins in a tertiary referral centre
13. Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC)
14. Retroperitoneal and Mesenteric Liposarcomas
15. A comparison of isolated limb infusion/perfusion, immune checkpoint inhibitors, and intralesional therapy as first‐line treatment for patients with melanoma in‐transit metastases.
16. BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian setting
17. Management of Retroperitoneal Sarcomas
18. International Center-Level Variation in Utilization of Completion Lymph Node Dissection and Adjuvant Systemic Therapy for Sentinel Lymph Node-Positive Melanoma at Major Referral Centers
19. Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched Analysis
20. Case report: Partial regression of metastatic squamous cell carcinoma with altered azathioprine dosage after long-term use in renal transplant patient.
21. Update of clinical practice guidelines for the management of patients with sarcoma.
22. Diagnosis and management of cutaneous melanoma
23. Australian general practitioners' attitudes and knowledge of sentinel lymph node biopsy in melanoma management
24. Correction to: Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC)
25. Spoiled for Choice: Do We Finally Have Clarity on Optimal Treatment Sequencing for Patients with Metastatic Melanoma Harboring an Actionable BRAF Mutation?
26. Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium
27. CD4 + T cell immunity against cutaneous melanoma encompasses multifaceted MHC II–dependent responses
28. Clinical activity in general practice before sarcoma diagnosis: an Australian cohort study.
29. Pleomorphic dermal sarcoma of the scalp - A single-centre experience
30. Management of Retroperitoneal Sarcomas
31. Adoptive Cell Therapy for Melanoma
32. Negative Sentinel Lymph Node Biopsy in Patients with Melanoma: The Patient’s Perspective
33. ASO Author Reflections: Standardization in the Management of Retroperitoneal Sarcoma Through International Collaboration
34. A systematic review of the role of chemotherapy in retroperitoneal sarcoma by the Australia and New Zealand Sarcoma Association clinical practice guidelines working party
35. Systemic Therapy for Melanoma: ASCO Guideline Update
36. Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis
37. Final 5-Year Follow-Up Results Evaluating Neoadjuvant Talimogene Laherparepvec Plus Surgery in Advanced Melanoma
38. Practical Management of Adult Ultra-Rare Primary Retroperitoneal Soft Tissue Sarcoma: A Focus on Perivascular Epithelioid Tumours and Extraosseous Ewing Sarcoma
39. Incidental Metastatic Melanoma Identified on 68Ga–Prostate-Specific Membrane Antigen PET/CT for Metastatic Prostate Cancer
40. ASO Author Reflections: The Impacts of a Negative Sentinel Lymph Node on Quality of Life
41. 30 - Cuidados perioperatorios: sarcoma y melanoma
42. 30 - Perioperative Care: Sarcoma and Melanoma
43. Preoperative Positron Emission Tomography for Node-Positive Head and Neck Cutaneous Squamous Cell Carcinoma
44. When is a sentinel node biopsy indicated for patients with primary melanoma? An update of the ‘Australian guidelines for the management of cutaneous melanoma’
45. Sentinel Lymph Node Biopsy in T4 Melanoma: An Important Risk-Stratification Tool
46. Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection
47. The efficacy of immune checkpoint blockade for melanoma in-transit with or without nodal metastases – A multicenter cohort study
48. NeoTrio: Randomized trial of neoadjuvant (NAT) pembrolizumab (Pembro) alone, in sequence (SEQ) with, or concurrent (CON) with dabrafenib plus trametinib (D+T) in resectable BRAF-mutant stage III melanoma to determine optimal combination of therapy.
49. Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma:Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC)
50. Endoscopic management of post-cholecystectomy biliary fistula
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.